Cochrane Database of Systematic Reviews 2008
DOI: 10.1002/14651858.cd006700.pub2
|Get access via publisher |Summarize |Cite|
|
Sign up to set email alerts

Acyclovir for treating primary herpetic gingivostomatitis

Abstract: We found two relevant trials in this systematic review, only one of them could provide some weak evidence that acyclovir is an effective treatment in reducing the number of oral lesions, preventing the development of new extraoral lesions, decreasing the number of individuals with difficulties experienced in eating and drinking and reducing hospital admission for children under 6 years of age with primary herpetic gingivostomatitis.

Search citation statements

Order By: Relevance

Paper Sections

Select...
45
0
0
0

Citation Types

0
7
0
0

Year Published

Range
2000
2000
2026
2026

Publication Types

Select...
25
19
1

Relationship

0
45

Authors

Journals

citations

Cited by 45 publications

(7 citation statements)
references

References 12 publications

0
7
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Because of the patient’s discomfort and the prolonged ICU treatment, oral aciclovir therapy 400 mg five times daily was administered, which resulted in rapid improvement of pain and ulcerations 4 . Given the patient’s age and the rare secondary manifestation of HSV‐1 in the oral cavity, we believe that the COVID‐19 infection and prolonged inpatient care were causal factors of stress induction and immunosuppression, leading to the distinct oral manifestations.…”
Section: Figure
mentioning
confidence: 99%